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Summary
Objective: The aims of this study were to assess changes in physical function and quality of life with the Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) and the instrument of the Medical Outcomes Study SF-36 Health Survey (MOS SF-36),
respectively, in patients undergoing hip and knee joint replacement surgery and to compare the responsiveness of these two outcome
measures 1 year after surgery.
Design: One hundred and ninety-four patients with osteoarthritis (OA knee 108, OA hip 86) admitted to four hospitals in Sydney were
followed over a period of 1 year at 3 monthly intervals.
Results: WOMAC measures improved significantly after 1 year for OA hip and OA knee: there was reduction in pain of 71% and 53%,
reduction in stiffness of 55% and 43% and improvement in physical function of 68% and 43%, respectively. MOS SF-36 measures in those
having hip surgery improved significantly for pain (222%), physical function (247%), physical role functioning (402%), general health (110%),
vitality (143%), social functioning (169%) and mental health (114%). For those in the knee surgery group, significant improvement was seen
for pain (175%), physical function (197%), physical role functioning (275%), vitality (125%) and social functioning (119%). The WOMAC was
a more responsive measure than the MOS SF-36.
Conclusion: WOMAC and MOS SF-36 detect significant and clinically meaningful changes in outcome after hip and knee replacement.
WOMAC requires a smaller sample size and is more responsive in the short term. For a follow-up longer than 6 months MOS SF-36 provides
additional information. The improvement in outcomes following hip joint surgery were significantly greater than those following knee surgery.
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8401.Introduction
Joint replacement has had a major impact on the manage-
ment of osteoarthritis (OA). Economically it requires an
important and increasing part of the health budget in every
country where it has been investigated. In the U.S.A. more137than 400 000 primary hip and knee arthroplasties are
performed each year and the annual costs of these proce-
dures were estimated to exceed US$ 10 billion1. In
Australia AUS$ 13.5 million Commonwealth benefits were
paid in the financial year 1997/98 for 17 000 hip and knee
replacements (customized tables, Health Insurance
Commission), compared to AUS$ 8.5 million in 1991/92 for
14 000 hip and knee replacements2. Expenditures on
primary joint arthroplasty surgery will increase in the future
with our aging population.
In clinical research, outcome instruments are of major
importance. They have to be valid, reliable and responsive
to change. The Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) is a multidimensional, self-
administered outcome measure, which has been devel-
oped by Bellamy3 for clinical trials in patients with hip or
knee osteoarthritis. It probes for the dimensions of pain (5
items), stiffness (2 items) and physical function (17 items).
It has been intensively validated4 and shown to be a valid,
reliable and responsive instrument. The Medical Outcomes
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STUDY POPULATION
This study is part of an ongoing large prospective trial
assessing costs of arthritis. Nine orthopedic surgeons in
four hospitals in Sydney, Australia (St Vincent’s Public and
Private Hospitals, the Centre for Bone and Joint Disease
and Mater Misericordiae) provided operation waiting lists
for total primary hip or knee joint replacement. Both pri-
vately insured and public (non-insured) patients were
included. All patients with a diagnosis of OA and rheuma-
toid arthritis were eligible to enter the study. Waiting lists
were checked fortnightly to monitor the continuing recruit-
ment. Patients were asked by telephone to take part in the
trial. In this paper only patients with OA were analysed.
Most patients were visited at home by the research assist-
ant for an interview after having signed a consent form, and
were also seen on admission for surgery. Follow-up was by
postal questionnaires or home visit if necessary. Follow-up
home visits were made to four hip replacement and eight
knee replacement patients. For two of the hip patients and
two of the knee patients reading English was a problem,
so the questions were read out to these people by the
interviewer. For the remainder, the questionnaires were
self-administered and the research assistant provided
assistance where necessary.ASSESSMENTS
Over a 12-month period the patients were mailed
WOMAC and MOS SF-36 questionnaires at 3-monthly
intervals. This analysis includes the first 12-month period of
follow-up. Shortly before the questionnaires were due back
patients were reminded by telephone calls. In case of
failure to respond the patients were again reminded by
telephone. Returned questionnaires were checked for
missing answers and clarified by telephone if necessary. To
minimize the drop-out rate patients were informed about
the study progress with quarterly newsletters and personal
contacts such as birthday cards.ANALYSIS
Data were entered using Paradox software and then
analysed using Statistical Package for Social Sciences
(SPSS) for Windows version 6.0 program9. Both question-
naires were scored according to guidelines of their
authors10,11. P-values ≤0.05 were considered significant.
Parametric Students t-tests (independent and paired tests)
were used to assess the significance of the mean differ-
ences before and after the operation, when scores were
approximately normally distributed. The non-parametric
test (Mann–Whitney U-Wilcoxon sum W test) was used for
the samples that were not normally distributed. Normality of
distribution was examined by standard diagnostic tests
(Lillefors test, box plot, normal probability plot and histo-
gram). The distribution of age, gender and duration of
disease in the groups of hip and knee joint replacement
were assessed by chi-squared tests (for the dichotomous
variable, gender) and independent t-tests (for continuous
variables). The change in the different domains was calcu-
lated as the difference of the pre-operative score to the
follow-up score. The improvement in the hip replacement
group compared to the knee replacement group was the
comparison of the mean score difference of the pre-
operative score and the follow-up score between the hip
and the knee replacement groups. These two comparative
analyses used paired tests limiting the calculations to those
people who completed both questionnaires at each time
point. These calculations required multiple comparisons.
Adaptation of the significance level was not performed. The
comparison of the improvement in the hip and knee
replacement groups was further assessed using multivari-
ate analysis to allow for age, gender and OA duration
as potential confounders. The models were created by
backward stepwise selection.
The estimates of the comparative responsiveness of the
two instruments were calculated with the relative efficiency
(RE) using the following formula)12:
This comparison is related to pain and physical function,
the only two dimensions measured in both questionnaires.
The MOS SF-36 scores on a 0–100 worst to best scale.
The WOMAC scores on a 1–5 best to worst scale, which
was transformed accordingly to the MOS SF-36 0–100
worst to best scale.Results
From 24 February 1994 to 1 July 1996, 376 patients with
OA on the waiting lists for hip or knee joint replacement
were eligible to take part in the study. Of these, 124 patients
did not take part in the study for the following reasons: 49
patients could not be contacted in time, 27 were not
interested, 18 felt too old or unwell, the English of 12
patients was too poor, seven patients could not be con-
tacted at the address provided by the surgeon, five patients
did not have a telephone to be contacted by, four patients
found the study too confusing and the operation was
cancelled in two patients. There was no difference in age,
sex or type of operation between those who provided pre-
and post-operative questionnaires and those who did not
take part in the study.Study SF-36 Health Survey (MOS SF-36) is a self-
administered, generic health-related quality of life instru-
ment. It was developed in the Rand Health Insurance
experiment from the Rand Health Insurance long form.
Quality of life is assessed by 36 items across eight dimen-
sions (physical functioning, role/physical functioning, bodily
pain, general health, vitality, social functioning, role/
emotional functioning, mental health). It has been tested for
its psychometric properties5,6. It has not been specially
designed for patients with OA but seems to be applicable to
a broad spectrum of diseases. Compared to the WOMAC it
is a more general instrument with the advantage of the
ability to assess pain, physical function and quality of life,
which are the most important outcomes in clinical trials with
osteoarthritic patients. The WOMAC and the MOS SF-36
have been recommended as valid outcome measures in
OA research at the OMERACT III conference7 and in the
guidelines of the Osteoarthritis Research Society8 to allow
standardization and comparability between studies. In this
study we wanted to quantify outcome after hip and knee
replacement using these two recommended measures, the
WOMAC and the MOS SF-36, and compare them prospec-
tively. We hypothesized that the WOMAC would be the
more efficient instrument, being disease-specific.
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corresponding to a response rate of 67.3%. Thirty-six
patients provided pre-operative questionnaires and with-
drew before providing post-operative questionnaires for the
following reasons: two patients died, in seven patients the
operation was cancelled, two patients moved from their
address and left no forwarding details and 25 patients
denied further participation in the study. These 36 patients
(14.3%) did not differ regarding sex and type of joint
replacement operation but were older compared to the 194
patients in the analysis (t= −2.506, P=0.013, mean age of
patients lost to follow-up and participants: 70±9.9 years
and 74±10.4 years, respectively). Twenty-two patients
started to provide pre-operative data but their first post-
operative questionnaire was answered after 1 July 1996.
For 194 patients (86 with OA of the hip and 108 with OA
of the knee) at least one pre-operative and one post-
operative WOMAC questionnaire was available. One hun-
dred and seventy-three patients (73 with OA of the hip and
100 with OA of the knee) provided at least one pre-
operative and one post-operative MOS SF-36 question-
naire in addition to the WOMAC questionnaires. Ninety-one
per cent of hip questionnaires were completed within 4
weeks prior to surgery, another 1.2% up to 5 weeks and
7.8% were longer than 5 weeks. For the knee patients, 88%
were completed within 4 weeks pre-surgery, another 4.5%
within 5 weeks and 7.5% in excess of 5 weeks. Where
questionnaires were completed in excess of 5 weeks prior
to surgery, these people were sent questionnaires, but did
not complete them immediately pre-operatively. The mean
time to surgery from pre-operative evaluation was 14.9
days for knee replacement patients and 14.2 days for hip
replacement patients.
The overall cohort was followed for a total of 2031
person-months, with an average of 11 months. For the hip
group, the total follow-up was 891 person-months (average
11 months) and for the knee group 1140 person months in
total (average 10 months).STUDY POPULATION CHARACTERISTICS
The study population characteristics of age, duration of
disease and gender distribution are listed in Table I. In
general, the patients in the hip replacement group were
younger (t-value= −5.27, 130 df, P<0.001) and had a
shorter duration of their disease (z-value= −2.68, P=0.007)
than those undergoing knee replacement surgery. Pre-
operatively all the domains in the WOMAC and the MOS
SF-36 were comparable between the two surgical cohorts
(WOMAC: pain P=0.19, stiffness P=0.99, physical function
P=0.52; SF-36: physical function P=0.78, role physical
function z= −1.69, pain P=0.46, general health P=0.16,vitality P=0.54, social function z= −1.86, role emotional
function P=0.68, mental health P=0.98).
Four in the hip group had their other hip replaced and
three in the knee group had their other knee replaced in the
12-month follow-up period. Those who had another joint
replaced did not differ significantly when WOMAC and
SF-36 scores were compared with those who had no
further joint replacement at the 12-month follow-up. There
was a low number of hospitalizations for adverse events
most probably related to the primary arthroplasty (3% hip
and 13% knee). These included 10 knee patients requiring
manipulation under anesthesia, three with an infection in
the operated joint and one knee patient and three hip
patients with thromboembolic complications. The 12-month
WOMAC and SF-36 measures showed a significant differ-
ence in WOMAC physical function only with those requiring
readmission to hospital within 12 months of knee arthro-
plasty reporting worse function at 12-month follow-up. No
significant differences were seen in the hip replacement
group in WOMAC or SF-36 scores at 12 months between
those requiring readmission and those who did not.
In addition, four knee replacement patients reported they
required hospitalization for arthritis-related conditions not
related to the primary replacement within the 12-month
follow-up period (such as neck pain due to arthritis, removal
of cartilage from other knee). These patients reported
significantly worse WOMAC pain, stiffness and function
at 12-month follow-up than all other knee replacement
patients (which includes those who were admitted for
another arthroplasty or for conditions likely to be related to
their primary arthroplasty). No difference was seen in any
scale of the SF-36.IMPROVEMENT OVER TIME IN THE HIP REPLACEMENT GROUP
ACCORDING TO WOMAC
The improvement over time in the patient group under-
going hip replacement surgery is shown in Fig. 1. In the hip
group there was a reduction in the mean scores of pain,
stiffness and physical function as assessed by the WOMAC
of about 50% in the first 3 follow-up months after the
operation. This improvement continued up to 1 year, when
the improvement in physical function and pain from base-
line was more than 60%. The changes were statistically
significant at 3, 6, 9 and 12 months for each of the WOMAC
dimensions.Table I
Baseline characteristics of patients*
Characteristic Hip replacement
group (N=86)
Knee replacement
group (N=108)
Entire surgical
group (N=194)
Age (years)† 65 (11.5) 72 (7.0) 69 (9.9)
Duration of disease (years)‡ 8.5 (9.4) 12.0 (11.9) 10 (11.1)
Female proportion (%) 39 61 52
*Providing at least one pre-operative and one post-operative WOMAC questionnaire.
†Mean (standard deviation).
‡Median (standard deviation).IMPROVEMENT OVER TIME IN THE KNEE REPLACEMENT GROUP
ACCORDING TO WOMAC
The patients undergoing knee replacement surgery
showed similar results (Fig. 2). The pre-operative scores
140 C. J. M. Bachmeier et al.: Outcome comparison after joint replacement surgeryFig. 1. WOMAC scores (means and standard deviations) in the patient group undergoing hip joint replacement surgery. *P<0.05. Lower
scores indicate a better health state. Baseline N=86; 3 months N=82; 6 months N=64; 9 months N=61; 12 months N=43.Fig. 2. WOMAC scores (means and standard deviations) in the patient group undergoing knee joint replacement surgery. *P<0.05. Lower
scores indicate a better health state. Baseline N=108; 3 months N=101; 6 months N=84; 9 months N=67; 12 months N=48.
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WOMAC improved after operation. The improvement com-
pared with baseline was statistically significant at 3, 6, 9
and 12 months. After 1 year the reduction in pain and
stiffness and the improvement in physical function was
each about 50%, respectively.IMPROVEMENT IN THE HIP REPLACEMENT GROUP COMPARED TO
THE KNEE REPLACEMENT GROUP ACCORDING TO WOMAC
The improvement in the hip joint replacement group
compared to the knee joint replacement group is shown in
Table II. The mean improvement in pain, stiffness and
physical function between baseline and the follow-ups were
more pronounced in patients who had undergone a hip
replacement compared with patients who had knee joint
replacement. Using univariate analysis the improvement
was statistically significantly greater at all follow-ups
regarding physical function, at follow-ups 9 and 12 months
regarding pain and at follow-ups 3 and 6 months regarding
stiffness. Multivariate analysis adjusting for age, sex and
duration of disease confirmed a greater improvement in
outcome for hip surgery patients at 9 months follow-up
(pain P=0.008, stiffness P=0.0001 and physical function
P=0.001, respectively) and at 12 months follow-up (pain
P=0.02, stiffness P=0.02 and physical function P=0.001,
respectively).IMPROVEMENT OVER TIME IN THE HIP REPLACEMENT GROUP
ACCORDING TO MOS SF-36
The improvement over time in patients undergoing hip
joint replacement is presented in Fig. 3(a) and (b) (the
domains of physical function, physical role function, bodily
pain and general health and the domains of vitality, social
function, emotional role function and mental health,
respectively). In the hip replacement group all eight
domains of the MOS SF-36 improved after the joint opera-
tion. The improvement in physical functioning, physical role
functioning, pain, vitality, social functioning and mental
health compared to baseline was statistically significant at
3, 6, 9 and 12 months. The improvement in general health
was statistically significant at 9 and 12 months, whereas
the improvement in emotional role functioning was statisti-
cally significant only at 9 months. The relative improvement
after 1 year was most pronounced for physical functioning
(247%) and physical role functioning (402%). These two
latter dimensions showed statistically significant improve-
ment also from 3–6 months. The quarterly improvementfor pain, vitality, social functioning and mental health
was statistically significant only for the first quarter
postoperatively.IMPROVEMENT OVER TIME IN THE KNEE REPLACEMENT GROUP
ACCORDING TO MOS SF-36
Figure 4(a) (physical function, physical role function,
bodily pain and general health) and (b) (vitality, social
function, emotional role function and mental health) present
the improvement over time in those undergoing knee joint
replacement surgery. In the knee replacement group all
domains of the questionnaire improved post-operatively
except general health, which was not influenced by the
surgical intervention. The improvement in physical function-
ing and pain was statistically significant at every follow-up,
whereas the improvement in physical role functioning,
vitality and social functioning was significant from 6 months
on. As in the hip group the relative improvement at one year
was most pronounced for the physical functioning (197%)
and the physical role functioning (275%).IMPROVEMENT IN THE HIP REPLACEMENT GROUP COMPARED TO
THE KNEE REPLACEMENT GROUP ACCORDING TO MOS SF-36
Table III shows the change in the outcome of patients
undergoing hip joint replacement surgery compared to
those undergoing knee joint replacement surgery. Com-
pared with patients after knee joint replacement, patients in
the hip replacement group had a greater improvement for
all domains at all follow-ups except regarding emotional
role functioning at 12 months as assessed by the MOS
SF-36. In univariate and multivariate analysis the greater
improvement was significant at most of the quarterly follow-
ups regarding physical function, pain and vitality. Signifi-
cantly greater improvement in the hip group regarding
physical role functioning using univariate analysis was
confirmed by multivariate analysis only at three months
post-operatively, whereas the greater improvement in men-
tal health in the hip group was significant at 9 and 12
months after adjusting for age, sex and OA duration.Table II
Improvement in the hip replacement group compared to the knee replacement group according to WOMAC
WOMAC domain Mean differences (95% CI) between hip and knee change from baseline scores to post-operative follow-up
3 months 6 months 9 months 12 months
N Hips: 79 Hips: 62 Hips: 67 Hips: 42
Knees: 101 Knees: 84 Knees: 59 Knees: 48
Pain −1.3 (−2.7,0.04) −0.9 (−2.4,0.6) −2.0 (−3.6,−0.5)* −2.6 (−4.6,−0.6)*
Stiffness −0.9 (−1.5,−0.2)* −0.8 (−1.4,−0.2)* −1.1 (−1.7,−0.5)* −0.8 (−1.6,0.1)
Physical function −4.3 (−8.7,0.0)* −5.2 (−9.4,−0.9)* −7.9 (−12.7,−3.0)* −10.8 (−17.1,−4.5)*
*P<0.05.
A negative score means a greater improvement in the hip replacement group.
CI=Confidence intervals.RELATIVE EFFICIENCY OF THE WOMAC COMPARED TO MOS SF-36
The WOMAC had a greater relative efficiency for pain
and physical function at all follow-ups except for physical
function in the knee replacement group at 12 months,
where both questionnaires are similarly efficient (Table IV).
142 C. J. M. Bachmeier et al.: Outcome comparison after joint replacement surgeryFig. 3. (a) The MOS SF-36 scores of the domains physical function, physical role function, bodily pain and general health (means and
standard deviations) in the patient group undergoing hip joint replacement surgery. *P<0.05. Higher scores indicate a better health state.
Baseline N=73; 3 months N=71; 6 months N=57; 9 months N=54; 12 months N=53. (b) The MOS SF-36 scores of the domains vitality,
social function, emotional role function and mental health (means and standard deviations) in the patient group undergoing hip joint
replacement surgery. *P<0.05. Higher scores indicate a better health state. Baseline N=73; 3 months N=71; 6 months N=57; 9 months
N=54; 12 months N=53.
Osteoarthritis and Cartilage Vol. 9, No. 2 143Fig. 4. (a) The MOS SF-36 scores of the domains physical function, physical role function, bodily pain and general health (means and
standard deviations) in the patient group undergoing knee joint replacement surgery. *P<0.05. Higher scores indicate a better health state.
Baseline N=100; 3 months N=89; 6 months N=77; 9 months N=66; 12 months N=51. (b) The MOS SF-36 scores of the domains vitality,
social function, emotional role function and mental health (means and standard deviations) in the patient group undergoing knee joint
replacement surgery. *P<0.05. Higher scores indicate a better health state. Baseline N=100; 3 months N=89; 6 months N=77; 9 months
N=66; 12 months N=51.
144 C. J. M. Bachmeier et al.: Outcome comparison after joint replacement surgeryThe greater relative efficiency of the WOMAC decreased
over time for both surgical groups regarding pain and
physical function. The relative efficiency of the WOMAC
was most pronounced for pain assessment in the knee joint
replacement group.Table III
Improvement in the hip replacement group compared to the knee replacement group according to SF-36
SF-36 domain Mean difference (95% CI) between hip and knee change from baseline score to post-operative follow up
3 months 6 months 9 months 12 months
N Hips: 66 Hips: 52 Hips: 49 Hips: 42
Knees: 88 Knees: 76 Knees: 63 Knees: 45
Physical function 10.7 (3.6,17.8)* 4.3 (−3.6,12.2) 8.4 (−0.2,17.0) 11.9 (1.6,22.3)*
Physical role function 17.3 (3.7,30.8)* 16.1 (0.5,31.7)* 17.0 (0.8,33.3)* 9.2 (−10.2,28.7)
Bodily pain 12.3 (4.5,20.2)* 8.2 (−1.2,17.6) 18.4 (8.4,28.4)* 18.5 (7.1,30.0)*
General health 6.2 (−0.5,12.9) 5.5 (−1.2,12.2) 10.9 (3.1,18.7)* 5.3 (−2.8,13.4)
Vitality 7.8 (−0.5,16.1) 8.0 (0.2,15.9)* 16.6 (8.3,24.9)* 11.2 (2.2,20.2)*
Social function 3.7 (−10.3,17.8) 3.9 (−8.5,16.3) 7.7 (−6.4,22.0) 9.5 (−5.2,24.3)
Emotional role function 6.2 (−12.2,24.6) 0.5 (−18.5,19.6) 5.2 (−16.2,26.5) −1.2 (−22.7,20.3)
Mental health 3.8 (−2.3,9.9) 1.7 (−4.5,7.8) 8.2 (0.7,15.5)* 7.4 (−0.2,15.0)
*P<0.05.
A positive score means a greater improvement in the hip replacement group.
CI=Confidence intervals.Table IV
The relative efficiency for WOMAC vs MOS SF-36
Follow-up
(months)
Pain Physical function
Hip Knee Hip Knee
0–3 1.43 1.94 1.73 1.73
0–6 1.54 1.92 1.40 1.17
0–9 1.42 1.84 1.48 1.24
0–12 1.13 1.74 0.99 1.30
Relative efficiency >1 if WOMAC is the more responsive
measure.Discussion
Eighty-six patients undergoing hip joint replacement and
108 patients undergoing knee joint replacement were
assessed pre-operatively and at 3-monthly follow-up
intervals post-operatively with WOMAC and MOS SF-36
questionnaires.
As ascertained by the WOMAC both patient groups
experienced significant improvement in pain, stiffness and
physical function. After 1 year, pain was reduced to 29%
and 47% of the pre-operative measures in the hip and knee
group, respectively, stiffness was reduced to 45% and 57%,
respectively and physical function increased by 68% and
43%, respectively. The greatest improvement was seen in
both groups within the first 3 months post-operatively. After
3 months all measures continued to improve with the
absolute values levelling off. A dramatic improvement by
three months and smaller changes thereafter in these
patients has been described previously13.
As assessed by the MOS SF-36 both patient groups
improved at all domains except that the general health of
patients after knee replacement remained unaltered. Again,
the greatest improvement in patients undergoing hip or
knee replacement was seen within the first 3 months
post-operatively. It seems a paradox that patients’ percep-
tion of their general health was not influenced after kneereplacement although significant changes in health status
could be demonstrated. An unchanged general health
status was seen previously in other 2-year follow-up
studies looking at total hip and knee arthroplasties
assessed by the MOS SF-3614,15. This may be explained
by the fact that even after a very successful operation pain
and restrictions in daily life remain post-operatively, which
are perceived by patients strongly enough to rate their
general health as insufficient. Perhaps this paradox reflects
some limitations of a generic health questionnaire which
does not include other important aspects of quality of life,
such as sleep and sexual function. Correlations between
pain reduction and functional independence and psycho-
logical well-being have been shown by others to be
inconsistent16.
Although patients in the hip and the knee replacement
group experienced improvement in virtually all domains
after their operation, the improvement was earlier and more
pronounced in patients with hip replacement for all domains
of the WOMAC and for physical function, pain, general
health, vitality and mental health assessed by the MOS
SF-36. The reason for these differences is not clear, as
there were no statistically significant differences in the
outcome measures at baseline and using multivariate
analysis potential confounders such as age, sex and dura-
tion of disease were adjusted for. Within this 1 year of
follow-up no patient had to undergo a revision of the study
knee or hip arthroplasty or a previously implanted hip or
knee replacement. It is possible that these differences
between hip and knee replacement groups could be
explained by a different rate of post-operative complica-
tions, which were slightly higher in the knee group. Comor-
bidities may also contribute; however, these were not
assessed. A greater relative improvement in osteoarthritic
hip vs knee replacement for pain and disability has been
described elsewhere17,18, including a 10-fold difference in
Quality Adjusted Life Years (QALYs) gained19 when hip
replacement (4 QALYs gained) were compared to knee
replacement (0.42 QALYs gained)20.
As a generic health status measure, the SF-36 has been
found to be more relevant and more responsive than the
Sickness Impact Profile and is the preferable generic health
status measure in patients undergoing hip replacement21.
In this study the disease-specific WOMAC was a more
responsive measure than the MOS SF-36. This was most
pronounced in the assessment of pain in patients with knee
Osteoarthritis and Cartilage Vol. 9, No. 2 145replacement. After 1 year the greater relative efficiency of
the WOMAC regarding ascertainment of pain and physical
function in both patient groups levelled somewhat com-
pared to the first months of observations. This may be
important for short-term studies with a duration of less than
1 year, where using the WOMAC questionnaire requires a
smaller sample size. In agreement with the results of this
study the WOMAC has been found to be the more sensitive
measure in detecting knee disabilities compared to the
MOS SF-3622. This is not surprising, as the WOMAC has
been developed as a specific outcome measure for
patients with OA of the lower limb.
Applying the MOS SF-36 questionnaire provided
additional information on the patients’ quality of life as
expressed by physical role functioning, general health,
vitality, social functioning, emotional role functioning and
mental health. This information is clinically important and
patient-relevant, as well as the more traditional outcomes
of pain, stiffness and physical function. Quality of life is a
major determinant of the patients’ global assessment of
satisfaction with their health status. Interestingly, quality of
life was slower to improve after the operation and the
relative changes were more subtle compared to the relative
improvement in physical outcome measures. Similarly, a
less dramatic improvement of psychological function com-
pared to pain was noted in a cohort study of patients
undergoing hip replacement surgery with a 6–8 week
follow-up23 which may reflect a slower adaptation of psy-
chological parameters compared to physical issues in a
new life situation.
The strengths of the study are its prospective design,
high participation and follow-up rate reducing well known
sources of biases of retrospective and cross-sectional
studies. The characteristics of the study population from
multiple orthopedic surgeons and its source both in private
and public hospitals should allow the generalizability of
the results. Comparable results have been reported in
American and British populations, but this is the first
Australian study published17,18,22. A further strength of this
study is the high power of the analyses: the comparison of
the WOMAC domains in both surgical groups had a power
well over 80%. A similar power was calculated for physical
function and bodily pain in the SF-36 questionnaire. Adjust-
ment for age, sex and disease duration was performed in
multiple regression analysis.
In summary, WOMAC and MOS SF-36 detect significant
and clinically meaningful changes in outcome after hip and
knee replacement. We conclude that the WOMAC is a
more responsive measure than the MOS SF-36, thus
requiring a smaller sample size. This is important when
designing short-term studies saving resources in time and
money. In studies with a follow-up longer than 6 months
MOS SF-36 provides useful additional information com-
pared with using the WOMAC alone. For long-term studies
it is useful to apply both the WOMAC and the MOS SF-36
questionnaires. After adjusting for age, gender and duration
of OA the WOMAC outcomes of pain, stiffness and function
and the SF-36 outcomes of pain, physical function, vitality
and mental health following hip joint replacement surgery
were greater than the improvement following knee joint
replacement.Acknowledgments
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